These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30026080)

  • 1. Dexamethasone prodrugs as potent suppressors of the immunostimulatory effects of lipid nanoparticle formulations of nucleic acids.
    Chen S; Zaifman J; Kulkarni JA; Zhigaltsev IV; Tam YK; Ciufolini MA; Tam YYC; Cullis PR
    J Control Release; 2018 Sep; 286():46-54. PubMed ID: 30026080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
    Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
    J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hepatic pDNA delivery system based on an intracellular environment sensitive vitamin E-scaffold lipid-like material with the aid of an anti-inflammatory drug.
    Togashi R; Tanaka H; Nakamura S; Yokota H; Tange K; Nakai Y; Yoshioka H; Harashima H; Akita H
    J Control Release; 2018 Jun; 279():262-270. PubMed ID: 29673647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation.
    Paunovska K; Sago CD; Monaco CM; Hudson WH; Castro MG; Rudoltz TG; Kalathoor S; Vanover DA; Santangelo PJ; Ahmed R; Bryksin AV; Dahlman JE
    Nano Lett; 2018 Mar; 18(3):2148-2157. PubMed ID: 29489381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA.
    Chen S; Tam YYC; Lin PJC; Sung MMH; Tam YK; Cullis PR
    J Control Release; 2016 Aug; 235():236-244. PubMed ID: 27238441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
    Zhang J; Haas RM; Leone AM
    Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the Inflammatory Pathway Enhances Both the in Vitro and in Vivo Transfection Activity of Exogenous in Vitro-Transcribed mRNAs Delivered by Lipid Nanoparticles.
    Ohto T; Konishi M; Tanaka H; Onomoto K; Yoneyama M; Nakai Y; Tange K; Yoshioka H; Akita H
    Biol Pharm Bull; 2019; 42(2):299-302. PubMed ID: 30713260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of Peptidomimetic Functionalized Cholesterol Based Lipid Nanoparticles for Efficient Delivery of Therapeutic Nucleic Acids.
    Ehexige E; Ganbold T; Yu X; Han S; Baigude H
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31546908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol.
    Rafique A; Etzerodt A; Graversen JH; Moestrup SK; Dagnæs-Hansen F; Møller HJ
    Int J Nanomedicine; 2019; 14():2829-2846. PubMed ID: 31114197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery.
    van der Meel R; Chen S; Zaifman J; Kulkarni JA; Zhang XRS; Tam YK; Bally MB; Schiffelers RM; Ciufolini MA; Cullis PR; Tam YYC
    Small; 2021 Sep; 17(37):e2103025. PubMed ID: 34337865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the role of helper lipids in lipid nanoparticle formulations of siRNA.
    Kulkarni JA; Witzigmann D; Leung J; Tam YYC; Cullis PR
    Nanoscale; 2019 Nov; 11(45):21733-21739. PubMed ID: 31713568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
    Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
    Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid Delivery.
    Sun D; Lu ZR
    Pharm Res; 2023 Jan; 40(1):27-46. PubMed ID: 36600047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticles as vehicles for macromolecules: nucleic acids and peptides.
    del Pozo-Rodríguez A; Delgado D; Solinís MA; Gascón AR
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):214-26. PubMed ID: 21834776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.
    de Jong S; Chikh G; Sekirov L; Raney S; Semple S; Klimuk S; Yuan N; Hope M; Cullis P; Tam Y
    Cancer Immunol Immunother; 2007 Aug; 56(8):1251-64. PubMed ID: 17242927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA.
    Kulkarni JA; Myhre JL; Chen S; Tam YYC; Danescu A; Richman JM; Cullis PR
    Nanomedicine; 2017 May; 13(4):1377-1387. PubMed ID: 28038954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
    Francia V; Schiffelers RM; Cullis PR; Witzigmann D
    Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
    Cheng X; Lee RJ
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the heterogeneity level in lipid nanoparticles for siRNA delivery: size-based separation, compositional heterogeneity, and impact on bioperformance.
    Zhang J; Pei Y; Zhang H; Wang L; Arrington L; Zhang Y; Glass A; Leone AM
    Mol Pharm; 2013 Jan; 10(1):397-405. PubMed ID: 23210488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the pharmacokinetic/pharmacodynamic properties of therapeutic nucleotides using lipid nanoparticle systems.
    Lin PJ; Tam YK
    Future Med Chem; 2015; 7(13):1751-69. PubMed ID: 26399560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.